Intractable Coronary Spasm Requiring Percutaneous Coronary Intervention after Coronary Artery Bypass Grafting in a

Hyeon A Kim1, Young Su Kim1, Wook Sung Kim1

  • 1Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Journal of Chest Surgery
|December 2, 2020
PubMed

Insights

Moyamoya disease patients can experience myocardial infarction from coronary spasm post-coronary artery bypass grafting. Successful treatment involved ECMO and PCI, highlighting a rare but serious complication.

Area of Science:

  • Cardiology
  • Neurology
  • Vascular Surgery

Background:

  • Moyamoya disease (MMD) involves progressive stenosis of major cerebral arteries, leading to cerebrovascular events.
  • Extracranial manifestations of MMD, including coronary artery issues like variant angina and myocardial infarction, are documented.
  • However, myocardial infarction following coronary artery bypass grafting (CABG) in MMD patients has not been previously reported.

Observation:

  • This report details a patient with Moyamoya disease who experienced cardiac arrest due to myocardial infarction.
  • The event occurred secondary to coronary artery spasm after undergoing off-pump CABG.
  • The patient required veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and percutaneous coronary intervention (PCI) for management.

Findings:

  • Myocardial infarction caused by coronary spasm is a potential complication in MMD patients undergoing CABG.
  • Successful management of this rare complication is achievable with advanced interventions like VA-ECMO and PCI.
  • This case underscores the importance of considering coronary artery spasm in MMD patients presenting with cardiac events post-CABG.

Implications:

  • This case highlights a previously undescribed complication of Moyamoya disease in the context of cardiac surgery.
  • It emphasizes the need for heightened vigilance regarding coronary artery spasm in MMD patients, especially those with a history of CABG.
  • The successful outcome suggests that aggressive management strategies, including VA-ECMO and PCI, can be effective in treating this rare but life-threatening condition.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
133
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
106
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
124
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
139
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
688
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
135